BioMarin presents VOXZOGO data ahead of ASBMR meeting

BioMarin said it will present data on VOXZOGO for children with achondroplasia and hypochondroplasia at the ASBMR 2026 Annual Meeting. The release also repeats safety information and notes plans tied to regulatory submissions and a PDUFA target date.